Wall Street Rewards Caliper Life Sciences on 22-Percent Q3 Revenue Growth

Nov 05, 2004

This article has been updated to include stock price.

NEW YORK, Nov. 5 (GenomeWeb News) - Shares in Caliper Life Sciences were up 4 percent to $7.02 in mid-afternoon trade after the company reported a 22-percent jump in third-quarter revenue and narrowed net losses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Main menu